Arch Biopartners Announces Start of GMP Manufacturing for AB569 at Dalton Pharma Services
TORONTO, ONTARIO--(Marketwired - May 4, 2017) - Arch Biopartners, Inc., (Arch or the Company) (TSX VENTURE:ARCH)(OTCBB:ACHFF) a portfolio-based biotechnology company, today announced Dalton Pharma Services (Dalton) has launched the good manufacturing …